We are live on ! Find out more
CIP

Capital Insight Partners Portfolio holdings

AUM $473M
1-Year Est. Return 14.93%
This Fund
S&P 500
This Quarter Est. Return
+0.41%
1 Year Est. Return
+14.93%
3 Year Est. Return
+51.75%
5 Year Est. Return
+52.67%
10 Year Est. Return
+181.46%
AUM
$98.4M
AUM Growth
-$444K
Cap. Flow
-$799K
Cap. Flow %
-0.81%
Top 10 Hldgs %
32.35%
Holding
65
New
10
Increased
31
Reduced
8
Closed
10

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$1.67M
2
WFC icon
Wells Fargo
WFC
+$1.54M
3
BKNG icon
Booking.com
BKNG
+$1.5M
4
GILD icon
Gilead Sciences
GILD
+$1.31M
5
HD icon
Home Depot
HD
+$1.17M

Top Sells

Rank Stock Value
1
BCS icon
Barclays
BCS
+$2.66M
2
F icon
Ford
F
+$2.42M
3
DATA
Tableau Software, Inc.
DATA
+$1.74M
4
PAG icon
Penske Automotive Group
PAG
+$1.53M
5
AVY icon
Avery Dennison
AVY
+$1.44M

Sector Composition

Rank Sector Weight
1 Technology 14.11%
2 Healthcare 14.05%
3 Financials 13.11%
4 Industrials 11.9%
5 Consumer Discretionary 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
1
GE Aerospace
GE
$364B
$3.8M 3.87%
24,957
-238
-0.9% -$33.6K
JNJ icon
2
Johnson & Johnson
JNJ
$640B
$3.54M 3.6%
32,694
+322
+1% +$33.3K
UL icon
3
Unilever
UL
$142B
$3.42M 3.48%
67,300
+30
+0% +$1.46K
ORCL icon
4
Oracle
ORCL
$339B
$3.09M 3.14%
75,582
+636
+0.8% +$23.5K
BAC icon
5
Bank of America
BAC
$429B
$2.96M 3.01%
219,175
+1,776
+0.8% +$24K
CL icon
6
Colgate-Palmolive
CL
$74.8B
$2.96M 3.01%
41,900
+76
+0.2% +$5.06K
PFE icon
7
Pfizer
PFE
$143B
$2.89M 2.94%
102,741
+2,077
+2% +$59.3K
NXPI icon
8
NXP Semiconductors
NXPI
$60.8B
$2.74M 2.78%
33,785
+739
+2% +$55.1K
VZ icon
9
Verizon
VZ
$197B
$2.73M 2.78%
50,483
+2,429
+5% +$121K
MAR icon
10
Marriott International
MAR
$100B
$2.72M 2.77%
38,251
-989
-3% -$64.7K
HON icon
11
Honeywell
HON
$76.4B
$2.71M 2.76%
26,948
+467
+2% +$43.8K
XOM icon
12
ExxonMobil
XOM
$650B
$2.68M 2.72%
32,022
+2,670
+9% +$214K
FDX icon
13
FedEx
FDX
$73B
$2.57M 2.61%
15,790
+645
+4% +$89.7K
GILD icon
14
Gilead Sciences
GILD
$165B
$2.54M 2.58%
27,676
+14,512
+110% +$1.31M
GSK icon
15
GSK
GSK
$107B
$2.47M 2.51%
48,649
+643
+1% +$32K
SPB icon
16
Spectrum Brands
SPB
$2.03B
$2.43M 2.47%
22,240
+9,395
+73% +$926K
CVS icon
17
CVS Health
CVS
$135B
$2.39M 2.43%
23,051
+456
+2% +$44.3K
EMC
18
DELISTED
EMC CORPORATION
EMC
$2.36M 2.4%
88,429
-2,325
-3% -$58.9K
JNPR
19
DELISTED
Juniper Networks
JNPR
$2.35M 2.39%
92,249
-246
-0.3% -$6.15K
META icon
20
Meta Platforms (Facebook)
META
$1.49T
$2.22M 2.25%
19,425
+119
+0.6% +$12.6K
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.12T
$2.16M 2.2%
56,700
+180
+0.3% +$6.63K
PRU icon
22
Prudential Financial
PRU
$42.6B
$2.09M 2.13%
28,978
+305
+1% +$21.3K
STI
23
DELISTED
SunTrust Banks, Inc.
STI
$2.05M 2.08%
56,817
+1,432
+3% +$51.6K
SLB icon
24
SLB Ltd
SLB
$72.7B
$1.96M 2%
26,631
+1,060
+4% +$74.5K
LYB icon
25
LyondellBasell Industries
LYB
$19.5B
$1.92M 1.95%
22,425
-730
-3% -$58.6K

Similar funds

Capital Insight Partners's Q1 2016 Portfolio in Review

As of Q1 2016, Capital Insight Partners held 65 positions worth $98.4M, down 0.45% from $98.8M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Capital Insight Partners's Q1 2016 filing shows 10 new, 31 increased, 8 reduced and 10 closed positions. Its largest new stake was Mastercard: 18,859 shares worth $1.78M. The largest sale was Barclays, an estimated $2.66M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Capital Insight Partners's largest Q1 2016 buy was Mastercard: 18,859 shares worth $1.78M.
  • Capital Insight Partners added most to Gilead Sciences in Q1 2016, an estimated $1.31M increase.
  • Capital Insight Partners's biggest Q1 2016 reduction was DAIMLER AG, cutting an estimated $1.12M.
  • Capital Insight Partners fully exited Barclays in Q1 2016, selling an estimated $2.66M.
  • Capital Insight Partners's ten largest holdings make up 32% of its $98.4M portfolio in Q1 2016.
  • Capital Insight Partners opened 10 new positions and closed 10 in Q1 2016.
  • Capital Insight Partners's portfolio value fell 0.45% quarter-over-quarter to $98.4M.

Based on Capital Insight Partners's 13F filing for Q1 2016, filed 6 Apr 2016.